The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin a1–thymopentin fusion peptide and its binding to TLR2
Hits:
|
|
The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin a1–thymopentin fusion peptide and its binding to TLR2
Hits:
|
|